drugset / Trial / NCT00549614
Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure
RandomizedCrossoverQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate whether metabolic modulation improves left ventricular function, work capacity, insulin sensitivity and modifies substrate metabolism in chronic heart failure
Timeline
- Start
- 2007-10
- Primary completion
- 2008-12
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acipimox | Small molecule | 250 mg | — |